中慧元通/怡道生物重组带状疱疹疫苗(CHO细胞)启动III期临床适应症为预防带状疱疹

动脉网
Oct 11, 2025

江苏中慧元通生物科技有限公司与上海怡道生物科技有限公司联合研发的重组带状疱疹疫苗(CHO细胞)已启动Ⅲ期临床试验,登记号CTR20254023,首次公示日期为2025年10月11日。该疫苗为注射剂,用于40岁及以上成人预防带状疱疹,接种方式为上臂三角肌肌内注射,每次0.5mL,共接种2次,分别在第0月和第2月进行。试验主要目的是评价全程接种后36个月内预防带状疱疹的保护持久性,次要目的为评价36个...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10